Method of treating atopic dermatitis with antibody to zcytor17 ligand
US8778344B2 · kind B2 · utility
16Cited by
21References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2012 |
| Grant date | Jul 15, 2014 |
| Priority date | — |
| Expiry date | Mar 29, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules. The zcytor17lig is a novel cytokine. The polypeptides may be used within methods for stimulating the immune system, and proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.